Safety and Tolerability of hRPC in Retinitis Pigmentosa

Clinical trial NCT02464436 · UNKNOWN

Trial details

NCT number: NCT02464436
Sponsor: ReNeuron Limited
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2015-12-01
Primary completion: 2022-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.